Modulation of the endocannabinoid and oxytocinergic systems as a potential treatment approach for social anxiety disorder (2019)
- Authors:
- USP affiliated authors: OSORIO, FLAVIA DE LIMA - FMRP ; ZUARDI, ANTONIO WALDO - FMRP ; HALLAK, JAIME EDUARDO CECILIO - FMRP ; CRIPPA, JOSÉ ALEXANDRE DE SOUZA - FMRP ; SANTOS, RAFAEL GUIMARÃES DOS - FMRP
- Unidade: FMRP
- DOI: 10.1007/s40263-019-00669-5
- Subjects: TRANSTORNOS DA ANSIEDADE; ANSIEDADE SOCIAL; CANABINOIDES
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
DOS SANTOS, Rafael Guimarães dos et al. Modulation of the endocannabinoid and oxytocinergic systems as a potential treatment approach for social anxiety disorder. CNS Drugs, v. 33, n. 10, p. 1031-1038, 2019Tradução . . Disponível em: https://doi.org/10.1007/s40263-019-00669-5. Acesso em: 27 dez. 2025. -
APA
Dos Santos, R. G. dos, Osório, F. de L., Martin-Santos, R., Zuardi, A. W., Hallak, J. E. C., & Crippa, J. A. de S. (2019). Modulation of the endocannabinoid and oxytocinergic systems as a potential treatment approach for social anxiety disorder. CNS Drugs, 33( 10), 1031-1038. doi:10.1007/s40263-019-00669-5 -
NLM
Dos Santos RG dos, Osório F de L, Martin-Santos R, Zuardi AW, Hallak JEC, Crippa JA de S. Modulation of the endocannabinoid and oxytocinergic systems as a potential treatment approach for social anxiety disorder [Internet]. CNS Drugs. 2019 ; 33( 10): 1031-1038.[citado 2025 dez. 27 ] Available from: https://doi.org/10.1007/s40263-019-00669-5 -
Vancouver
Dos Santos RG dos, Osório F de L, Martin-Santos R, Zuardi AW, Hallak JEC, Crippa JA de S. Modulation of the endocannabinoid and oxytocinergic systems as a potential treatment approach for social anxiety disorder [Internet]. CNS Drugs. 2019 ; 33( 10): 1031-1038.[citado 2025 dez. 27 ] Available from: https://doi.org/10.1007/s40263-019-00669-5 - Cannabidiol for the treatment of drug use disorders
- Cannabidiol for the treatment of epilepsy: an overview of possible mechanisms of action and preclinical and human studies
- Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 years
- O uso do canabidiol (CBD) no tratamento da doença de Parkinson e suas comorbidades
- Rapid and sustained decreases in suicidality following a single dose of ayahuasca among individuals with recurrent major depressive disorder: results from an open-label trial
- Neuropharmacological effects of the main phytocannabinoids: a narrative review
- Acute harmine administration induces antidepressive-like effects and increases BDNF levels in the rat hippocampus
- Memory-rescuing effects of cannabidiol in an animal model of cognitive impairment relevant to neurodegenerative disorders
- Administration of harmine and imipramine alters creatine kinase and mitochondrial respiratory chain activities in the rat brain
- Cannabidiol normalizes caspase 3, synaptophysin, and mitochondrial fission protein DNM1L expression levels in rats with brain iron overload: implication for neuroprotection
Informações sobre o DOI: 10.1007/s40263-019-00669-5 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
